Lv5
920 积分 2023-03-20 加入
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
10小时前
待确认
Blocking only the bad side of IL-6 in inflammation and cancer
2个月前
已完结
Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits TH17 cell expansion
3个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development
5个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
9个月前
已完结
Endothelial cells as paracrine mediators of long COVID
1年前
已完结
Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas
1年前
已完结
A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity
1年前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
1年前
已完结
皖公网安备34019202002308
